September 2016 – Valence Newsletter

  • No slowdown in chemicals M&A activity as structural realignment, low growth and strong profits continue to underpin the market
  • Companies are optimizing M&A through additional cost synergies, scale benefits and enhanced revenue growth
  • Transaction valuations are robust as demand for quality businesses remains resilient – “is 15x the new 10x?”

Download Chemical M&A Review Sept 2016